bharat biotech covid vaccine

Bhubaneswar: The founder and chairman of Bharat Biotech Krishna Ella visited Bhubaneswar on Wednesday and informed that the Covid-19 vaccine production will start in Odisha by June 2022. The vaccine production unit will be set up on the…
Read More...

New Delhi: Bharat Biotech concluded the final analysis of its Covid-19 vaccine Covaxin and announced the safety and efficacy analysis data from Phase 3 clinical trials on Saturday. According to the analysis, Covaxin has been found to be…
Read More...

New Delhi: The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs,…
Read More...

New Delhi: The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.…
Read More...

Bhubaneswar: Bharat Biotech’s Covaxin that aims to protect against COVID-19, has arrived in Bhubaneswar today. As many as 53,270 doses of Covaxin vaccine has reached at the Biju Patnaik International Airport (BPIA). Reportedly, these…
Read More...

New Delhi:  The Union Health Ministry on Tuesday fixed the charges for administration of COVID vaccines by private hospitals. The price for the administration of Covishield, Covaxin and Sputnik V has been decided based on the prices that…
Read More...

New Delhi: Amid the Covid vaccine shortage in the country during the ongoing vaccination drive, Bharat Biotech has dispatched its vaccine to 30 cities in a month, informed Co-Founder & Joint Managing Director Suchitra Ella. "COVAXIN…
Read More...

New Delhi: Clinical trials to test Covaxin vaccine's efficacy in children between two to 18 years of age will begin in 10-12 days, top officials said on Tuesday. Addressing the Union Health Ministry press conference, NITI Aayog's Member…
Read More...

New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin got approved by an expert panel on Tuesday for phase II and III human clinical trials on those between 2-18 years of age. The Subject Expert Committee (SEC) on Covid-19 of the Central…
Read More...

Hyderabad: Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states. The states are Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha,…
Read More...